Australian radiopharma Telix launches bid for Nasdaq listing
Telix Pharmaceuticals, a radiopharma drug and diagnostics maker, has started its march toward a listing on the Nasdaq, submitting its initial
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
